NCT04361903
Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection Not Available Not Available unknown_status NCT04349202
Beaumont Health Large-scale Automated Serologic Testing for COVID-19 No drug interventions Not Available Not Available completed NCT04402879
CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals No drug interventions treatment Not Available unknown_status NCT04602351
Communication in ICU During COVID-19 No drug interventions Not Available Not Available completed NCT04461353
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers treatment 1 completed NCT04477993
Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 treatment 2 / 3 terminated NCT04702178
A Clinical Trial of COVAC-2 in Healthy Adults No drug interventions prevention 1 completed NCT04359407
Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients No drug interventions Not Available Not Available completed NCT04379037
Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients No drug interventions treatment Not Available completed NCT04423770
COVID-19 Related Health and Infection Control Practices Among Dentists No drug interventions Not Available Not Available completed NCT04667936
Evaluation of Sedation in COVID-19 ARDS No drug interventions Not Available Not Available completed NCT04522986
An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection treatment 1 completed NCT04452565
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection prevention 2 / 3 unknown_status NCT05155982
A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy Adults prevention 1 withdrawn NCT04626089
Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2 No drug interventions treatment 2 withdrawn NCT04367740
ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 No drug interventions Not Available Not Available completed NCT04365101
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 treatment 1 / 2 unknown_status NCT04357938
Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections No drug interventions Not Available Not Available completed NCT04707703
Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis prevention 3 terminated NCT04354779
Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. No drug interventions Not Available Not Available completed NCT04343053
Pro-thrombotic Status in Patients With SARS-Cov-2 Infection No drug interventions diagnostic Not Available active_not_recruiting NCT04375098
Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection treatment 2 completed NCT04987528
Pulmonary Fibrosis During Severe COVID-19 Pneumonia No drug interventions Not Available Not Available active_not_recruiting NCT04516811
Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 treatment 3 unknown_status NCT04371978
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 treatment 3 terminated NCT04367207
African Covid-19 Critical Care Outcomes Study No drug interventions Not Available Not Available unknown_status NCT05209009
A Clinical Trial of COVAC-2 in Adults No drug interventions prevention 2 completed NCT04625985
Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. No drug interventions treatment 2 completed NCT04423042
Tocilizumab in Coronavirus-19 Positive Patients treatment 3 unknown_status NCT04732949
Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 treatment 3 completed NCT04466241
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial treatment 2 / 3 unknown_status NCT05543616
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children prevention 2 / 3 recruiting NCT04711863
Fluvoxamine for Adults With Mild to Moderate COVID-19 treatment 2 suspended NCT04360486
Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP) No drug interventions Not Available Not Available no_longer_available NCT04519125
Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia prevention 2 / 3 unknown_status NCT04661631
Surgery and Lung Ultrasound in COVID-19 Infection No drug interventions Not Available Not Available unknown_status NCT04409873
Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) supportive_care 2 terminated NCT04375176
Monocytes and NK Cells Activity in Covid-19 Patients No drug interventions Not Available Not Available unknown_status NCT04376476
Host-pathogen Interactions During SARS-CoV-2 Infection No drug interventions other Not Available completed NCT04402060
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 treatment 1 / 2 completed NCT04334044
Treatment of SARS Caused by COVID-19 With Ruxolitinib treatment 1 / 2 completed NCT04333368
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS No drug interventions treatment 1 / 2 completed NCT05947812
A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression treatment 2 not_yet_recruiting NCT04381923
COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia No drug interventions supportive_care Not Available withdrawn NCT04920838
Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection treatment 2 / 3 unknown_status